Sonora Authorities Investigate Deaths Linked to Vitamin IV Drips; Suspect Sought
Translated from Spanish, summarized and contextualized by DistantNews.
TLDR
- Authorities in Sonora, Mexico, are investigating the deaths of eight people allegedly linked to vitamin IV drips.
- Investigations include searches, exhumations, and business closures, with a suspect identified as Jesรบs Maximiano โNโ for alleged medical malpractice.
- Six businesses offering similar treatments have been temporarily suspended as part of broader health verification efforts.
In the state of Sonora, Mexico, a grave investigation is underway following the deaths of eight individuals, with authorities suspecting a connection to vitamin IV drips. The State Attorney General's Office (FGJE) has launched a comprehensive strategy involving searches, exhumations, and the closure of establishments to ensure justice and reparations for the victims. The primary suspect, identified as Jesรบs Maximiano โN,โ is being investigated for negligent homicide stemming from alleged medical malpractice. Authorities are actively pursuing his capture. This unfolding situation has raised serious concerns about the regulation and safety of wellness treatments, which are often promoted as beneficial but can carry significant health risks if not administered correctly. The FGJE has conducted five searches across the state and obtained authorization for exhumations to precisely determine the causes of death. In parallel, health authorities have inspected 24 similar establishments, leading to the preventive suspension of six businesses to safeguard public health. The state's Executive Commission for Victim Care is providing integral support to the families affected, offering legal counsel and institutional assistance. This case underscores the critical need for stringent oversight of medical and wellness practices to prevent such tragic outcomes.
Originally published by El Universal in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.